Julie Gralow
Medical Oncology
Credentials: · ·
History
- 1991–1994
Hematology and Medical Oncology
- 1988–1991
Internal Medicine
Research
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
New England Journal of Medicine · 2007 · 2,445 citations
Current and future burden of breast cancer: Global statistics for 2020 and 2040
The Breast · 2022 · 2,275 citations
The Lancet Oncology · 2010 · 1,100 citations
Gabriel Hortobagyi
48 papers
- RL
40 papers
35 papers
- EP
28 papers
- DH
25 papers
- GE
23 papers
22 papers
20 papers
Grants
- 2010–2017
Seattle Cancer Consortium Breast SPORE
National Cancer Institute · P50
Project lead · $1.5M · Fred Hutchinson Cancer Research Center
- 1995–1998
National Cancer Institute · R03
Contact PI · $135.2K · University of Washington
Clinical trials
- 2024–2028
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Principal investigator · Recruiting · Phase 3
American Society of Clinical Oncology
- 2020–2025
ASCO Survey on COVID-19 in Oncology (ASCO) Registry
Principal investigator · Unknown
American Society of Clinical Oncology
- 2018–2019
Principal investigator · Completed
Fred Hutchinson Cancer Center
- 2001–2008
Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial
Principal investigator · Terminated · Phase 1, Phase 2
University of Washington